A D Victor Holanda1, Laila Asth1, Adair R Santos2, Remo Guerrini3, Vanessa de P Soares-Rachetti1, Girolamo Calo'4, Eunice André5, Elaine C Gavioli6. 1. Behavioral Pharmacology Laboratory, Department of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Natal, RN, Brazil. 2. Departamento de Ciências Fisiológicas, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil. 3. Department of Chemistry and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. 4. Department of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy. 5. Department of Pharmacology, Federal University of Parana, Curitiba, PR, Brazil. 6. Behavioral Pharmacology Laboratory, Department of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Natal, RN, Brazil. Electronic address: egavioli@hotmail.com.
Abstract
AIMS: The present study aimed to investigate the intraplantar (ipl) and central (icv) effects of neuropeptide S (NPS) in the formalin test and to evaluate the role of adenosine receptors, mainly A1 and A2A, in mediating such effects. MAIN METHODS: The ipl injection of formalin was used to assess the nociceptive activity. Moreover, by pretreating mice with non-selective and selective antagonists of adenosine receptors, the effects of icv NPS on formalin-induced ongoing nociception were assessed. KEY FINDINGS: Morphine-induced antinociceptive effects were observed during phases 1 and 2 of the test, while indomethacin was active only at the later nociceptive phase. The ipl injection of NPS (alone or combined with formalin) did not modify the nociceptive response. However, icv NPS significantly reduced formalin-induced nociception during both phases. Caffeine (3 mg/kg, ip), a non-selective adenosine receptor antagonist, prevented NPS-induced antinociceptive effects. Similar to caffeine, icv ZM241385 (0.01 nmol), an A2A receptor antagonist, prevented the antinociceptive effects of NPS. Moreover, icv DPCPX (0.001 nmol), an A1 receptor antagonist, blocked the effects of NPS only during phase 1. SIGNIFICANCE: The above findings suggest that: (i) NPS evokes central antinociceptive effects by activating both A1 and A2A receptors during phase 1, but (ii) only the adenosine A2A receptor during phase 2 of the formalin test.
AIMS: The present study aimed to investigate the intraplantar (ipl) and central (icv) effects of neuropeptide S (NPS) in the formalin test and to evaluate the role of adenosine receptors, mainly A1 and A2A, in mediating such effects. MAIN METHODS: The ipl injection of formalin was used to assess the nociceptive activity. Moreover, by pretreating mice with non-selective and selective antagonists of adenosine receptors, the effects of icv NPS on formalin-induced ongoing nociception were assessed. KEY FINDINGS:Morphine-induced antinociceptive effects were observed during phases 1 and 2 of the test, while indomethacin was active only at the later nociceptive phase. The ipl injection of NPS (alone or combined with formalin) did not modify the nociceptive response. However, icv NPS significantly reduced formalin-induced nociception during both phases. Caffeine (3 mg/kg, ip), a non-selective adenosine receptor antagonist, prevented NPS-induced antinociceptive effects. Similar to caffeine, icv ZM241385 (0.01 nmol), an A2A receptor antagonist, prevented the antinociceptive effects of NPS. Moreover, icv DPCPX (0.001 nmol), an A1 receptor antagonist, blocked the effects of NPS only during phase 1. SIGNIFICANCE: The above findings suggest that: (i) NPS evokes central antinociceptive effects by activating both A1 and A2A receptors during phase 1, but (ii) only the adenosine A2A receptor during phase 2 of the formalin test.
Authors: Juliane Cabral Silva; Raimundo Gonçalves de Oliveira Júnior; Mariana Gama E Silva; Érica Martins de Lavor; Juliana Mikaelly Dias Soares; Sarah Raquel Gomes de Lima-Saraiva; Tâmara Coimbra Diniz; Rosemairy Luciane Mendes; Edilson Beserra de Alencar Filho; Eliezer Jesus de Lacerda Barreiro; Lídia Moreira Lima; Jackson Roberto Guedes da Silva Almeida Journal: PLoS One Date: 2018-07-30 Impact factor: 3.240
Authors: Maria Alice Miranda Bezerra Medeiros; Mariana Gama E Silva; Jackson de Menezes Barbosa; Érica Martins de Lavor; Tiago Feitosa Ribeiro; Cícero André Ferreira Macedo; Luiz Antonio Miranda de Souza Duarte-Filho; Thiala Alves Feitosa; Jussara de Jesus Silva; Harold Hilarion Fokoue; Cleônia Roberta Melo Araújo; Arlan de Assis Gonsalves; Luciano Augusto de Araújo Ribeiro; Jackson Roberto Guedes da Silva Almeida Journal: PLoS One Date: 2021-11-24 Impact factor: 3.240